GLP-1 stands for glucagon-like peptide-1, a class of medication for obesity and type 2 diabetes that acts like the regular hormones that are supposed to regulate blood sugar and tell people when their appetites are sated
The average list price of Wegovy (the only semaglutide-based drug currently approved for obesity) is around $1,300 a month, while Ozempic (approved for diabetes but sometimes prescribed off-label for weight loss) is around $1,000 monthly
Changes in vision in patients with type 2 diabetes
This work was funded by the National Research, Development and Innovation Office of Hungary, grant numbers NNE-29617 (M-ERA.NET2 nanoPD) and K143766 (for M.A.D.)
The pens clear labelling and included sterile needles enhance safety while ensuring hygienic administration each week
Can I combine GLP-1 treatment with other weight loss methods